RE: £54 per share14 Mar 2022 21:26
Tell u what would be a larf B2H is TATA.
If they truly aspire to be all over India then # Fully Automated Promate is exactly what they require. No temp transport issues , massive array of tests.
Coffers overspilling , DHSC dispute means nothing to them in the grand scheme of things. High enough offer and every shareholder bites their hand. Right now they are a customer , has Nova told them about future developments like the 10 minute nat tests , what Ruo products non covid they are working on to work with Promate. Ncyt have the expertise inhouse , pounce when it's ready to roll ? Perhaps Bio thinks that scenario above is inevitable.
Bio directors as I posted before own personally over 54 % of the company. Anything they buy is like a personal investment .
If JV doesn't fly then they must be certain they will gain financially by investing.
Tick Tock.